<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">HJO</journal-id><journal-title-group><journal-title>Hans Journal of Ophthalmology</journal-title></journal-title-group><issn pub-type="epub">2167-6542</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/HJO.2017.62008</article-id><article-id pub-id-type="publisher-id">HJO-20884</article-id><article-categories><subj-group subj-group-type="heading"><subject>HJO20170200000_50801445.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  1例Leber遗传性视神经病变早期诊断和治疗
  An Early Case of Leber’s Hereditary Optic Neuropathy to Diagnose and Treat
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>王</surname><given-names>丹</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>项</surname><given-names>楠</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>吴</surname><given-names>晨冕</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>马</surname><given-names>思琪</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>元</surname><given-names>佳佳</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>刘</surname><given-names>畅</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>李</surname><given-names>斌</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>null</addr-line></aff><aff id="aff2"><addr-line>华中科技大学同济医学院附属同济医院眼科，湖北 武汉</addr-line></aff><pub-date pub-type="epub"><day>07</day><month>06</month><year>2017</year></pub-date><volume>06</volume><issue>02</issue><fpage>45</fpage><lpage>50</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  
    LHON发病是因为线粒体DNA位点突变导致能量不足，视神经细胞萎缩甚至死亡。rAAV2-ND4提供正常的ND4，增加能量供应，有潜力治愈LHON。我们观察了一例视神经受损早期的患者，希望能进一步明确早期诊断、治疗对于LHON的影响，此病例中，患者病程短，发病后迅速予以营养神经、能量供给后患者视力曾恢复至OD:0.8 OS:0.6。
    LHON is caused by a point mutation in mtDNA, which leads to a reduction in energy production by the mitochondria. Because optic nerve tissue requires much more energy than other tissues, it becomes severely damaged when energy production drops, and pathological changes in optic nerve cells and even atrophy can occur. Given the results of the present study, it seems potential to suppose that rAAV2-ND4 therapy supplied normal ND4 to the mitochondria, and thus increased energy supply to the optic nerve. We observed an early case to explore how to diagnose and treat matters earlier. In this case, the patient was newly attacked. He got medicine for energy and nerve nutrition almost immediately. His visual acuity of right eye was improved to 0.8, which of the left eye was improved to 0.6. 
  
 
</p></abstract><kwd-group><kwd>Leber遗传性视神经病，视神经炎，母系遗传，线粒体眼病，早期治疗，基因治疗, Leber’s Hereditary Optic Neuropathy</kwd><kwd> Optic Neuritis</kwd><kwd> Maternal Inheritance</kwd><kwd> Mitochondrial Eye Disease</kwd><kwd> Early Treatment</kwd><kwd> Gene Therapy</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1例Leber遗传性视神经病变早期诊断和治疗<sup> </sup></title><p>王丹，项楠，吴晨冕，马思琪，元佳佳，刘畅，李斌<sup>*</sup></p><p>华中科技大学同济医学院附属同济医院眼科，湖北 武汉</p><disp-formula id="hanspub.20884-formula1"><graphic xlink:href="http://html.hanspub.org/file/1-2230146x5_hanspub.png"  xlink:type="simple"/></disp-formula><p>收稿日期：2017年5月15日；录用日期：2017年6月4日；发布日期：2017年6月7日</p><disp-formula id="hanspub.20884-formula2"><graphic xlink:href="http://html.hanspub.org/file/1-2230146x6_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>LHON发病是因为线粒体DNA位点突变导致能量不足，视神经细胞萎缩甚至死亡。rAAV2-ND4提供正常的ND4，增加能量供应，有潜力治愈LHON。我们观察了一例视神经受损早期的患者，希望能进一步明确早期诊断、治疗对于LHON的影响，此病例中，患者病程短，发病后迅速予以营养神经、能量供给后患者视力曾恢复至OD:0.8 OS:0.6。</p><p>关键词 :Leber遗传性视神经病，视神经炎，母系遗传，线粒体眼病，早期治疗，基因治疗</p><disp-formula id="hanspub.20884-formula3"><graphic xlink:href="http://html.hanspub.org/file/1-2230146x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2017 by authors and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="http://image.hanspub.org:8080\Html/htmlimages\1-2890033x\e70a10f1-7c93-45ea-9603-062237856e4b.png" /><img src="http://image.hanspub.org:8080\Html\htmlimages\1-2890033x\e898c85e-ffc4-45c9-b817-14224a4d6960.png" /></p></sec><sec id="s3"><title>1. 前言</title><p>LHON临床表现为双眼急性或亚急性中心视力下降，主要累及青年至成年男性。LHON发病是因为线粒体DNA位点突变导致能量不足，视神经细胞萎缩甚至死亡，我们已经试过给9例病人单侧玻璃体腔内注射rAAV2-ND4，增加能量供应，9个月的随访后，其中6名患者的视力明显提升，随访过程中也没有发生注射相关并发症或其他并发症。这9例病人病程较长，仍取得了不错的效果，我们希望能观察早期病例的治疗与预后情况，因此观察了一例视神经受损早期的患者。</p></sec><sec id="s4"><title>2. 病例介绍</title><p>患者万XX，男，14岁。2016.8.30日因“双眼视物模糊2月余”于华中科技大学同济医学院附属同济医院就诊。2月前无明显诱因出现双眼视物模糊，视力下降，渐进性加重，闭眼时自觉眼前活动性亮点，当地医院予以(“激素”、抗生素)，“营养神经药物”等治疗。视力曾好转，OD 0.5 OS 0.3，激素减量过程中，出现视力下降，遂就诊。</p><p>专科体格检查：视力OD 0.4 OS 0.1，眼压0D 20 mmHg OS 18 mmHg，眼前段(-)，眼底：双眼视盘充血，边界尚清，黄斑中心凹反光尚可，余视网膜平伏。</p><p>辅助检查：输血前八套(-)；血常规：白细胞10.70 &#215; 10~9/L，中性粒细胞6.27 &#215; 10~9/L，淋巴细胞3.51 &#215; 10~9/L；EB病毒核抗原IgG抗体定量569.0(+)，巨细胞病毒IgG抗体89(+)。眼底照相显示：双眼视盘充血，边界清，未见明显异常(图1)。视野检查显示：双眼中心视野缺损，右眼生理盲点扩大(图2)。眼球及眼眶MR结果显示：双眼视神经迂曲，结合临床视神经炎可能。视盘OCT及黄斑OCT未见明显异常。眼底荧光血管造影未见明显异常(图3)。</p><p>入院后初步诊断为：视神经炎，予以激素冲击，营养神经、护胃、补钾、补钙等治疗。结合患者年龄及发病特征，LHON的诊断不能排除，送检线粒体mtDNA基因G3460A、G11778A、T14484C三个位点检测，同时行头部MRI等相关检查。</p><p>视野检查显示：双眼中心视野缺损，右眼生理盲点扩大(图2)。</p><p>治疗一周后，患者视力稍提高OD 0.6 OS 0.05，头部MR：双侧额叶点状异常信号，考虑为炎性脱髓鞘病变。患者基因检测：G11778A发现异常变异，此时，再三追问病史，得知其舅舅，母亲的外公有类似视力下降史。似乎两个诊断的证据都在加强，我们分析：一种可能是视神经炎，同时伴有11,778位点突变，但LHON没有发病；一种可能是LHON发病，不是视神经炎；还有一种可能是视神经炎，同时诱使LHON发病。</p><p>为明确诊断，我们进一步做AQP4抗体检测和颈椎平扫，同时对患儿三代行线粒体mtDNA基因三个位点检测。两周后患者视力OD0.8 OS 0.15，复查视野，视野缺损较前稍好转，眼底视盘充血较前减轻，似乎偏向于视神经炎的诊断。</p><p>AQP4抗体(-)，颈椎平扫未见异常。根据患儿三代行线粒体mtDNA基因三个位点检测情况，结合患儿家族视力下降史，绘制家系图谱如下(图4)。</p><p>图1. 眼底照相。显示双眼视盘充血，边界清，未见明显异常</p><p>图2. 视野检查：双眼中心视野缺损，右眼生理盲点扩大</p><p>图3. 眼底荧光造影。双眼未见明显异常</p><p>患者视力恢复良好，2016.9.14日视力OD0.8 OS 0.15，出院诊断：LHON，视神经炎待排？继续激素，营养神经治疗，2016.9.26日门诊复查，患儿视力好转，OD:0.8 OS:0.5，瞳孔对光发射灵敏，RAPD(-)，继续随访，2016.10.11日患者视力进一步好转，OD:0.8 OS:0.6，2016.11.1日，患儿突发双眼视力急剧下降，伴眼胀，眼压0D 20 mmHg OS 18 mmHg，视力OD 0.3 OS 0.25。体格检查：双眼视盘边界尚清，C/D约为0.3，颜色偏红，黄斑中心凹反光尚可，余视网膜平伏。入院检查：血常规(-)。予以扩管、营养神经、改善循环、改善能量代谢，2016.11.2日，患者视力显著提升，OD 0.5 OS 0.3。然而，之后患儿视力持续下降，2016.11.11日患儿视力OD 0.3 OS 0.12。此后患儿视力下降反复发作，予以营养神经对症支持治疗后好转，短暂好转后再发视力下降，复查视神经厚度尚可(图5)，至今2017.1.17日患者门诊复查时，患儿视力OD 0.1 OS 0.1。</p><p>图4. 眼底荧光造影。双眼未见明显异常</p><p>图5. 患者2016-8-31日与2017-1-5日视神经纤维层厚度对比</p></sec><sec id="s5"><title>3. 讨论</title><p>此例患者诊断具有极大的困难性，当时认为有三种可能：一种可能是视神经炎，同时伴有11,778位点突变，但LHON没有发病；一种可能是LHON发病，不是视神经炎；还有一种可能是视神经炎，同时诱使LHON发病。</p><p>当时几乎是同时获得了视神经炎和LHON两方面的证据。首先，本例患者为青壮年男性，视力损害严重，无眼部疼痛或转眼痛，眼底未见明显视乳头萎缩，眼底可见视盘充血，眼球及眼眶MR结果显示：双眼视神经迂曲，结合临床视神经炎可能。激素治疗后好转，在采集病史时，“视神经炎性疾病”的诊断极大地迷惑了我们。其次，头部MR：双侧额叶点状异常信号，考虑为炎性脱髓鞘病变，再次干扰了我们的诊断。最终瞳孔对光反射灵敏，RAPD(-)，AQP-4抗体阴性，眼底荧光造影(-)帮助排除了视神经炎诊断。而在患者再次发病，仅使用扩管、营养神经、改善循环、改善能量代谢后，患者视力提高，则侧面映证我们排除视神经炎诊断的正确性，至此，才完全确诊患者为LHON。</p><p>LHON临床表现为双眼急性或亚急性中心视力下降，主要累及青年至成年男性 [<xref ref-type="bibr" rid="hanspub.20884-ref1">1</xref>] - [<xref ref-type="bibr" rid="hanspub.20884-ref6">6</xref>] 。线粒体突变是其发病基础，迄今为止已经发现不少于30个与之相关的线粒体突变位点，临床上的患者都与3种原发性线粒体突变(G3460A, G11778A, T14484C)有关 [<xref ref-type="bibr" rid="hanspub.20884-ref7">7</xref>] [<xref ref-type="bibr" rid="hanspub.20884-ref8">8</xref>] [<xref ref-type="bibr" rid="hanspub.20884-ref9">9</xref>] 。</p><p>本病的临床诊断主要依赖典型的临床表现并排除其他引起视神经萎缩的疾病，如视神经炎、多发性硬化、视神经脊髓炎及其谱系疾病、营养性弱视等。临床上可出现散发的不明原因的视神经病变。视神经炎是一种由病毒或细菌感染、代谢障碍、中毒或脱髓鞘等病因引起的视神经炎症，多发于青少年或中年，临床上表现为视力下降、视野缺损、瞳孔对光反射迟钝等，与LHON存在较多相似性 [<xref ref-type="bibr" rid="hanspub.20884-ref10">10</xref>] 。因而两者难以鉴别，对于临床提示为视神经炎或LHON者，如条件允许，因尽可能仔细进行眼部体格检查，并详细询问病史、家族史，并行眼底荧光造影和基因检测等相关检查，以明确诊断。</p><p>LHON目前尚无特效治疗方法 [<xref ref-type="bibr" rid="hanspub.20884-ref11">11</xref>] ，最理想的治疗方法应是基因治疗 [<xref ref-type="bibr" rid="hanspub.20884-ref12">12</xref>] ，但目前市面上仍无相关基因治疗药物上市。因此，临床上对LHON主要采取对症治疗，某些患者(如本例中的患者)经治疗后视力轻度回升是治疗效果还是遗传学上的异质性等因素所造成的，有待进一步研究观察。</p><p>此病例中，患者病程短，发病后迅速予以营养神经、能量供给后患者视力恢复至OD:0.8 OS:0.6，对于此类视神经受损程度较轻的病患，若能及时给予基因治疗，持续加强能量供应，是否就能保住患者的视力？在后续工作中我们将进一步观察LHON早期疗效。</p></sec><sec id="s6"><title>文章引用</title><p>王 丹,项 楠,吴晨冕,马思琪,元佳佳,刘 畅,李 斌. 1例Leber遗传性视神经病变早期诊断和治疗An Early Case of Leber’s Hereditary Optic Neuropathy to Diagnose and Treat[J]. 眼科学, 2017, 06(02): 45-50. http://dx.doi.org/10.12677/HJO.2017.62008</p></sec><sec id="s7"><title>参考文献 (References)</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.20884-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">周和政. 黄震晞. Leber氏遗传性视神经病变的临床研究进展[J]. 华南国防医学杂志, 2004, 18(6): 33-36.</mixed-citation></ref><ref id="hanspub.20884-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Martin-Kleiner, I., Cabrilovac, J., Bradvac, M., et al. (2006) Leber’s Hereditary Optic Neuroretinopathy (LHON) Associated with Mitochondrial DNA Point Mutation G11778A in Two Croatian Families. Collegium Antrop-ologicum, 30, 171-174.</mixed-citation></ref><ref id="hanspub.20884-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Wallace, D.C. (1999) Mitochondrial Diseases in Man and Mouse. Science, 283, 1482-1488.  
&lt;br&gt;https://doi.org/10.1126/science.283.5407.1482</mixed-citation></ref><ref id="hanspub.20884-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Brown, M.D., Trounce, I.A., Jun, A.S., et al. (2000) Func-tional Analysis of Lymphoblast and Cybrid Mitochondria Containing the G3460A, G11778A, or T14484C Lbber’s Hereditary Optic Neuroretinopathymitochondrial DNA Mutation. The Journal of Biological Chemistry, 275, 39831-39836. &lt;br&gt;https://doi.org/10.1074/jbc.M006476200</mixed-citation></ref><ref id="hanspub.20884-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Quiros, P.Av., Torres, R.J., Salomao, S., et al. (2006) Colour Vision Defects in Asymptomatic Carriers of the Lbber’s Hereditary Optic Neuroretinopathy (LHON) mtDNAG11778A Mutation from a Large Brazilian LHON Pedigree: A Case-Control Study. The British Journal of Ophthalmology, 90, 150-153. &lt;br&gt;https://doi.org/10.1136/bjo.2005.074526</mixed-citation></ref><ref id="hanspub.20884-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Qu, J., Li, R., Zhou, X., Tong, Y., et al. (2006) The Novel A4435G Mutation in the Mitochondrial tRNAMet May Modulate the Phenotypic Expression of the LHON-Associated ND4 G11778A Mutation. Investigative Ophthalmology &amp; Visual Science, 47, 475-483. &lt;br&gt;https://doi.org/10.1167/iovs.05-0665</mixed-citation></ref><ref id="hanspub.20884-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Mashima, Y., Yamada, K., Wakakura, M., Kigasawa, K., Kudoh, J., Shimizu, N., et al. (1998) Spectrum of Pathogenic Mitochondrial DNA Mutations and Clinical Features in Japanese Families with Lbber’s Hereditary Optic Neuroretinopathy. Current Eye Research, 17, 308-403. &lt;br&gt;https://doi.org/10.1080/02713689808951221</mixed-citation></ref><ref id="hanspub.20884-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">王燕, 郭向明, 贾小云, 黎仕强, 肖学珊, 郭莉, 等. 中国人Leber遗传性视神经病变的原发突变及临床特征[J]. 中华医学遗传杂志, 2005, 22(3): 334-336.</mixed-citation></ref><ref id="hanspub.20884-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Howell, N. (1997) Lbber Hereditary Optic Neuropathy: Mitochondrial Mutations and Degeneration of the Optic Nerve. Vision Re-search, 37, 3495-3507. &lt;br&gt;https://doi.org/10.1016/S0042-6989(96)00167-8</mixed-citation></ref><ref id="hanspub.20884-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Balcer, L.J. (2006) Clinical Practice. Optic Neuritis. The New England Journal of Medicine, 354, 1273-1280.  
&lt;br&gt;https://doi.org/10.1056/NEJMcp053247</mixed-citation></ref><ref id="hanspub.20884-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Balayre, S., Gicquel, J.J., Mercie, M., et al. (2003) Childhood Leber Hereditaryoptic Neuropathy. A Case of a 6-Year- Old Girl with Loss of Vision. Journal Francais D’Ophtalmologie, 26, 1063-1066.</mixed-citation></ref><ref id="hanspub.20884-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Koilkonda, R.D., Chou, T.H., Porciatti, V., et al. (2010) Induction of Rapid and Highly Efficient Expression of the Human ND4 Complex I Subunit in the Mouse Visual System by Self-complementary Adeno-Associated Virus. Archives of Ophthalmology, 128, 876-883. &lt;br&gt;https://doi.org/10.1001/archophthalmol.2010.135</mixed-citation></ref></ref-list></back></article>